Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. (Q38485521)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 May 2015

Language	Label	Description	Also known as
English	Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.	scientific article published on 14 May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

phase II clinical trial

0 references

multicenter clinical trial

0 references

1 reference

ChEBI release 2020-05-28

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Reinhard Dummer

23

object named as

Reinhard Dummer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Michael R Migden

1

object named as

Michael R Migden

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Patrick Combemale

6

object named as

Patrick Combemale

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ragini R Kudchadkar

8

object named as

Ragini Kudchadkar

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

9

object named as

Uwe Trefzer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

10

object named as

Sven Gogov

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

11

object named as

Celine Pallaud

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Alexander Guminski

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ralf Gutzmer

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Luc Dirix

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Karl D Lewis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Robert M Herd

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Tingting Yi

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Manisha Mone

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Martin Kaatz

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Carmen Loquai

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Alexander J Stratigos

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hans-Joachim Schulze

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ruth Plummer

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Anne Lynn S Chang

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Frank Cornélis

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Dalila Sellami

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

14 May 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

716-728

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Basal cell carcinomas: attack of the hedgehog

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Update of the European guidelines for basal cell carcinoma management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging drugs and combination strategies for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral hedgehog-pathway inhibitors for basal-cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)70100-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25981810%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38485521&oldid=1984401463"